Scientists find genetic oddity protects sex cells

Researchers have found that a class of RNA molecules previously thought to have no function may in fact protect sex cells from self-destructing.

The findings from MIT, the Whitehead Institute for Biomedical Research and the Institute for Systems Biology in Seattle were reported in the Nov. 17 issue of the journal Cell.

Central to this discovery is the fundamental process of gene expression.

When a gene is ready to produce a protein, the two strands of DNA that comprise the gene unravel. The first strand produces a molecule called messenger RNA, which acts as the protein's template. Biologists call this first strand of DNA the "sense" or "coding" transcript.

Even though the other strand doesn't contain a protein recipe, it may also, on occasion, produce an "antisense" RNA molecule, one whose sequence is complementary to that of the messenger, or sense, RNA. Antisense RNA has been detected for a number of genes, but is largely considered a genetic oddity.

Using common baker's yeast, Cintia Hongay, a postdoctoral researcher in the lab of Whitehead member and MIT Biology Professor Gerald Fink, discovered that in the case of a gene called IME4, the antisense RNA blocks the sense RNA. In other words, the gene disables its own ability to make protein.

"This is the first case where a specific function in a higher cell for antisense RNA has been found," said Fink, senior author on the paper. "This points to an entirely new process of gene regulation that we've never seen before in eukaryotic cells."

There is a method to this sense/antisense madness, one that has a kind of yin and yang quality.

When conditions around yeast cells are good and rich in nutrients, the cells divide by mitosis--that is, the DNA duplicates so each daughter cell receives exactly the same number of chromosomes as the original cell. However, when the yeast cells are starving, IME4 switches on and activates a process called meiosis. Here, the cells divide into germ-cell spores that, like mammalian egg and sperm cells, have half the number of chromosomes. Yeast spores withstand this harsh environment far more ably than the larger cells from which they originate.

But in some cases, flipping the meiotic switch can be catastrophic. If a cell with only one copy of each chromosome (a haploid cell) is forced into meiosis, the progeny won't survive. Fortunately, such destructive meiotic division is avoided in haploid cells because they continually produce IME4 antisense RNA, blocking the production of sense RNA. Antisense IME4, then, safeguards against meiosis in cells that can't handle it.

"For years scientists have evaluated genomes by measuring the sense RNA, with antisense transcripts thought to have no meaning at all," says Fink. "Here we've found a process in which antisense RNA regulates sense RNA. This same process may occur in the sex cells of mammals. In fact, considering how widespread these antisense transcripts are, I wouldn't be surprised if these findings eventually lead us to discover an entirely new level of gene regulation."

Hongay is now searching the yeast genome for other genes that might be regulated by antisense RNA.

Source: MIT

Related stories:

Researchers discover novel 'gene toggles' in world's top food crop
University of Delaware researchers, in collaboration with U.S. and international colleagues, have found a new type of molecule--a kind of “micro-switch”--that can turn off genes in rice, which is the primary source of food for more than half the world's population. The discovery is reported in the March 25 issue of the Proceedings of the National Academy of Sciences of the United States of America.
Scientists devise potential approach to treat spinal muscular atrophy
In the neuromuscular disease called spinal muscular atrophy, or SMA, a protein deficiency caused by a single gene mutation leads to serious damage in growing nerve cells and the muscles they control.
MicroRNAs may be key to HIV's ability to hide, evade drugs
Tiny pieces of genetic material called microRNA (miRNA), better known for its roles in cancer, could be a key to unlocking the secrets of how HIV, the AIDS virus, evades detection, hiding in the immune system. Researchers at Jefferson Medical College in Philadelphia have shown that when an individual infected with HIV receives a powerful cocktail of antiviral agents called HAART (highly active antiretroviral therapy), the virus calls on miRNAs to help it remain quiet and practically undetectable, temporarily shutting down its ability to replicate and infect.
Scientists discover role for dueling RNAs
Researchers have found that a class of RNA molecules, previously thought to have no function, may in fact protect sex cells from self-destructing. These findings will be published in the November 17 issue of the journal Cell.
Gold nanoparticles could improve antisense cancer drugs
In the fight against cancer, antisense drugs, which prevent genes from producing harmful proteins such as those that cause cancer, have the promise to be more effective than conventional drugs, but the pace of development of these new drugs has been slow.
Accumulated bits of a cell's own DNA can trigger autoimmune disease
A security system wired within every cell to detect the presence of rogue viral DNA can sometimes go awry, triggering an autoimmune response to single-stranded bits of the cell's own DNA, according to a report in the August 22nd issue of the journal Cell, a Cell Press publication. The source of that single-stranded DNA is so-called endogenous retroelements—genetic elements accounting for a substantial portion of the genome that can move to new locations using a "copy and paste" mechanism, according to the researchers.
Molecular sleuths track evolution through the ribosome
A new study of the ribosome, the cell's protein-building machinery, sheds light on the oldest branches of the evolutionary tree of life and suggests that differences in ribosomal structure between the three main branches of that tree are "molecular fossils" of the early evolution of protein synthesis.
Experiments could lead to new treatments for neuroblastoma
Neuroblastoma is one of the most devastating diagnoses a child can receive. The cancer's victims average 2 years old when the disease is detected, most often by a parent feeling a lump in a child's abdomen. By then, the disease has often reached an advanced stage, and advanced neuroblastoma kills more than 50 percent of the children in whom it develops, despite aggressive treatment with surgery, chemotherapy and radiation.

News discussion:

Medicine & Health news